Re: 34 week prom

From: Robert J. Carpenter, Jr. MD (zygote@icsi.net)
Sat Apr 9 12:24:40 2005


I am unaware of any prospective controlled study after 32 weeks. The original liggins-Howie data did not go that far and most other studeis have nopt done som since it would take a substantial number oif patients in each cell. I single dose of Celestone will not harm child and if you believe it is appropriate then give it. Challenge them to show you data that it is not effective.

I have used it in the past and will use in the future in that situation. Bob

On 9 Apr 2005 at 11:15, Andrew Folley wrote:

> Garry, what do you think of steroids for prom at 32-34 weeks. Our
> MFMs are saying no benefit shown after 32. I know I have read studies
> of giving steroids at 32 to 34 and then delivering 48 hours later.
> andy
>
> >From: garrys@mindspring.com (Garry E. Siegel, M.D.)
> >Reply-To: ob-gyn-l@obgyn.net
> >To: Multiple recipients of list OB-GYN-L <ob-gyn-l@dns.obgyn.net>
> >Subject: Re: 34 week prom Date: Fri, 8 Apr 2005 21:55:34 -0500
> >
> >ROM at 34 or more--expectant management or deliver.
> >
> >No steroids over 34 weeks.
> >
> >Garry
> >
> >At Fri, 08 Apr 2005, Andrew Folley wrote:
> > >
> > >Lynn thanks for such a clear anc concise response. Over the past
> > >yar I
> >have
> > >been pushing for giving steroids antibiotics and tocolysis for
> > >PPROM at 32-34 weeks and cytokine release etc and role in causing
> > >cerebral palsy.
> >Do
> > >you think that is too aggressive at this point??? andy
> > >
> > >>From: "Lynn D. Montgomery, M.D." <apgar10@montanadsl.net>
> > >>Reply-To: ob-gyn-l@obgyn.net
> > >>To: Multiple recipients of list OB-GYN-L <ob-gyn-l@dns.obgyn.net>
> > >>Subject: RE: 34 week prom Date: Fri, 8 Apr 2005 14:04:10 -0500
> > >>
> > >>This issue has been addressed with several abstracts over the past
> > >>two years at the Society meeting. Because of the increased
> > >>incidence of neurodevelopmental issues associated with children
> > >>who are products of PPROM over controls with just prematurity, the
> > >>effects of various inflammatory markers (i.e. cytokines,
> > >>metalloproteinase's, interlukins)have been
> >looked
> > >>at. Granted, some of these studies are animal models, but
> > >>exposure of brain tissue to these substances has impressive
> > >>effects. Because these
> >factors
> > >>are produced prior to clinical evidence of infection, and thus the
> > >>potential untoward effects on the fetus, it has been suggested to
> > >>move the point
> >at
> > >>which you electively deliver, with PPROM, earlier that what I was
> > >>taught
> >at
> > >>36 weeks. Data is pretty conclusive that 34 weeks is the more
> > >>prudent timing - issues regarding prematurity are outweighed by
> > >>the risk of neurodevelopmental issues - and the fact that the
> > >>ultimate outcome of pregnancies beyond 34 weeks is the same. One
> > >>paper actually goes as far
> >as
> > >>suggesting that 32 weeks is the more prudent "end-point" in PPROM.
> > >> I haven't yet been convinced to go that far.
> > >>
> > >>A year ago at the Society meeting, because of what these various
> > >>papers suggested, I polled several programs represented, asking
> > >>them what their policy was with regard to timing of delivery with
> > >>PPROM and the
> >predominate
> > >>answer was 34 weeks.
> > >>Lynn
> > >>
> > >>Lynn D. Montgomery, M.D.
> > >>Maternal-Fetal Medicine, OB/GYN
> > >>Rocky Mountain Women's Health
> > >>2835 Fort Missoula Rd., Suite 304
> > >>Missoula, Montana, 59804
> > >>406-549-0978
> > >>fax 406-549-0987
> > >>e-mail: apgar10@montanadsl.net
> > >>
> > >>-----Original Message-----
> > >>From: ob-gyn-l@obgyn.net [mailto:ob-gyn-l@obgyn.net] On Behalf Of
> > >>Andrew Folley Sent: Thursday, April 07, 2005 10:16 AM To: Multiple
> > >>recipients of list OB-GYN-L Subject: RE: 34 week prom
> > >>
> > >>Question: Had a patient show up last night G3P2 ruptured
> > >>membranes 34 weeks 1 day. 2 prior c-sections. Not in Labor. What
> > >>to do? She is vertex
> >fluid
> > >>in vault sent for f-pole showed not mature. My plan was steroids,
> > >>tocolysis for 48 hours if necessary and repeat c-section in 48
> > >>hours. Along with GBS prophylaxis. Some of our MFMs were not so
> > >>happy with the management plan. What ywoud you do???? andy
> > >>
> > >> >
> > >>
> > >>it's
> >FREE!
> > >>_________________________________________________________________
> > >>
> > >>_________________________________________________________________
> > >_________________________________________________________________
> > >On the road to retirement? Check out MSN Life Events for advice on
> > >_________________________________________________________________
> > >how to
> > >
> > >--
> > >_________________________________________________________________
> > >get there! http://lifeevents.msn.com/category.aspx?cid=Retirement
> > >_________________________________________________________________
> > >
> >
> >--
> >Garry E. Siegel, M.D.
> >Private Practice
> >Roswell, GA
>
> _________________________________________________________________ FREE
> pop-up blocking with the new MSN Toolbar – get it now!
> _________________________________________________________________ FREE
> http://toolbar.msn.click-url.com/go/onm00200415ave/direct/01/
>

--
Robert J. Carpenter, Jr. MD
6624 Fannin, #2720
St. Luke's Medical Tower
Houston,TX 77030-2339
713-795-4600




use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Wed Jul 2 04:39:23 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.